“A Quick Guide to Clinical Trials” Book Review
A brief review of “A Quick Guide to Clinical Trials,” edited by Dr. Madhu Davies and Dr. Faiz Kermain.
May 14, 2008-“A Quick Guide to Clinical Trials,” edited by Dr. Madhu Davies and Dr. Faiz Kermain, and offered by BioPlan Associates, truly lives up to its title. While it could serve as a textbook for a primer class on the clinical trials industry, the quick read would be suitable for anyone wishing to learn more about clinical trials-including people outside or inside the industry. If you are in data management, for example, and want to learn more about ethics in clinical research-or vise versa-this would be a useful resource. The book consists of 14 chapters dedicated to a different segment of the clinical trials process, each written by an industry expert. The information is up-to-date and offers personal, yet professional, insights into the current issues applicable to that segment.
For more information or to purchase, contact: www.bioplanassociates.com/quickGuides.
Reaching Diverse Patient Populations With Personalized Treatment Methods
January 20th 2025Daejin Abidoye, head of solid tumors, oncology development, AbbVie, discusses a number of topics around diversity in clinical research including industry’s greatest challenges in reaching diverse patient populations, personalized treatment methods, recruitment strategies, and more.
Merck Stops HYPERION Trial for Winrevair in PAH Following Positive ZENITH Trial Results
January 30th 2025The Phase III HYPERION trial was stopped early after strong positive interim results from the ZENITH trial demonstrated the efficacy of Winrevair (sotatercept-csrk) in treating pulmonary arterial hypertension, making it unethical to continue.
